EMD Millipore, proud sponsor of the 2011 Conversations with Experts Luncheons, invites all attendees to join informal roundtable discussions focusing on all aspects of stem cells and regenerative medicine, including science, business, public policy, social, ethical, education, advocacy and commercialization strategies. This luncheon is a unique opportunity to build strategic relationships and have your questions answered. 

EMD Millipore is a world-class Life Science partner that offers cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a leading Stem Cell tools provider and strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research through development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals.

Expert Luncheon Day 1
Monday, October 3, 2011 - 1:00 PM - 2:30 PM (Eastern Time)

“Conversations with Experts” Luncheon

“MSC's in clinical trials: delivering effective therapies”
Arnold Caplan, PhD, Professor of Biology and General Medical Sciences, Case Western Reserve University
Science / Industry

“ IPS Technologies: Positives and Negatives”
James Eliason, PhD, Director, Stem Cell Commercialization Center, Tech Town, Wayne State University
Science / Industry

“Overcoming the Obstacles to Growing Whole Organs”
Tracy Grikscheit, MD, Assistant Professor of Surgery, Children’s Hospital Los Angeles
Science/ Industry

“Amniotic Fluid Stem Cells”
Laura Perin, PhD
Assistant Professor Urology, Children’s Hospital Los Angeles
Science/Industry

Karen Aboody, MD
Associate Professor, Neurosciences, City of Hope
Science / Industry

"The critical role of stem cells in toxicity studies"
Prue Talbot, Professor of Cell Biology, Director, UCR Stem Cell Center and Stem Cell Core Facility
Science / Industry

“The important clinical implications of parthenogenetic stem cell research”
Bill Adams, Co-founder, International Stem Cell Corporation
Science / Industry

“Stem Cells in Drug Discovery and Toxicity Testing”
Dr. Knut Niss, Manager R&D, Stem Cell Initiative, EMD Millipore
Science / Industry

“cGMP Manufacture of Stem Cells”
Bob Shaw, Commercial Director, Stem Cell Initiative, EMD Millipore
Science / Industry

“Stem Cell Characterization and Assays”
Victor Koong, Product Manager - Stem Cells/Cell Biology, EMD Millipore
Industry/Science
Science / Industry

“Stem Cell Quality Assurance- Avoiding Early Stage Pitfalls.”
Rob Herrera, CEO, Cell Line Genetics
Science / Industry

“Start-Up Nation-  Research and Commercial Collaboration Opportunities in Israel”
Avi Treves,PhD and Amon Pelz, Sheba Medical Center and Taburit
Science / Industry

“From Dolly to Dollars: Collaboration Opportunities in Scotland”
Kevin Price,CEO, Scottish Stem Cell Network
Science/Industry

“Systematising the derivation of lineage-restricted stem cells”
Michael West, PhD, CEO, BioTime
Science / Industry

“Bringing regenerative medicine to big business”
Stephen Minger, PhD, GE Healthcare
Science / Industry

“Endogenous Stem Cells – Promise and Possibilities”
Paul Patterson, PhD, Caltech
Science / Industry

“Cardiac regeneration in the zebra fish model- human implications”
Michael Harrison, PhD, Children’s Hospital Los Angeles
Science/Patient

“Stem Cells Derived from Cord Blood- Expected Return on Investment.”
Claudia Zylberberg, PhD, CEO, Akron Biotech
Science / Industry

“Current and Future Trends in the Regenerative Medicine Industry”
Lee Buckler, Managing Partner, Cell Therapy Group
Industry

“Business Models for Autologous Cell Therapy”
Elona Baum, JD, General Counsel, California Institute for Regenerative Medicine
Industry

"Pathways to a Skilled Stem Cell Workforce"
Pamela Eversole-Cire, Ph.D.
Director, Biological Technology Program, Pasadena City College
Education/Industry

“Identifying the right partners for investment or acquisition”
Scott Burger, MD, Advanced Cell & Gene Therapy, LLC
Industry/Finance

“Industry Perspectives from the Alliance for Regenerative Medicine”
Robert Margolin
Industry/regulation

“Changing Landscape- NIH Funding for Biomedical Research.”
Max Bronstein, Manager of Science & Policy, Research!America
Policy/Advocacy

"International Challenges in Embryonic Stem Cell Science"
John Hearn, Chief Executive, Worldwide Universities Network
Regulation

“Stem Cell Legislation Across the EU – Trends
Pitfalls and Opportunities for Academic Research and Industry”
Timo Faltus, Dip. Jur. Dipl. Biol., University of Leipzig
Regulation

“Stem Cell Science and Regenerative Medicine in the Internet Cloud, Apps, and Social Media: the Ix in Rx/Dx/Px/Ix” 
Alan Jakimo, MBA, JD, Partner, Sidley Austin, LLP
Regulation

"Pointers on Interacting with the FDA on Cell Therapy Matters"
Steve Bauer, PhD
FDA, Division of Cellular and Gene Therapies
Regulation

“The Untold Story of the Discovery of Stem Cells by Till & McCulloch”
Joe Sornberger, Author of "Dreams & Due Diligence – Till & McCulloch’s Stem Cell Discovery and Legacy" and James Price, CEO, Canadian Stem Cell Foundation
Science/Industry/ Public education

“Prospects for stem cell therapies for Parkinson's Disease”
Xianmin Zeng, PhD, Buck Institute for Aging Research
Science/Patient focus

“Stem cell therapies for the lung”
David Warburton, MD, Children’s Hospital Los Angeles
Science/Patient focus

“Prospects for Regenerative Medicine Against Aging”
Aubrey de Grey, PhD, The SENS Foundation
Science / Society

“Stem Cell Action – Building National Advocacy Movement State by State”
Victoria Kohout, Executive Director, Nebraska Coalition for Life Saving Cures
Patient focus / Advocacy

“Parental Ethics and Funding Challenges in Pediatric Neurology Treatments”
Mary Schneider, Legislative Advocate, Children’s Neurobiological Solutions (CNS) Foundation
Patient focus

“Focus on Diabetes”
Meri Firpo, PhD, University of Minnesota Stem Cell Institute
Patient focus

“Focus on Spinal Cord Injury”
Sabrina Cohen, Executive Director, Sabrina Cohen Foundation for Stem Cell Research
Patient focus

“Focus on ALS”
Stephen Byer, Founder, ALS Worldwide
Patient focus

“Newmie from Baywatch and Svendsen from Cedars talk about Parkinson’s disease”
Michael Newman,Advocate and Clive Svendsen, Director, Cedars-Sinai Regenerative Medicine Institute
Patient focus/Science